Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arndt Hartmann

Showing results (811-820 of 933) with videos related to

Pageof 94
Sort By:
Cancers|April 30, 2021
Implementation of Double Immune Checkpoint Blockade Increases Response Rate to Induction Chemotherapy in Head and Neck CancerSabine Semrau, Antoniu-Oreste Gostian, Maximilian Traxdorf, et al.
European Journal of Cancer (Oxford, England : 1990)|December 12, 2018
Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumabMarkus Eckstein, Philipp Erben, Maximilian C Kriegmair, et al.
Geburtshilfe Und Frauenheilkunde|July 31, 2018
Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients - a Survey Among PhysiciansPaul Gass, Michael Untch, Volkmar Müller, et al.
European Urology Oncology|July 14, 2026
FGFR3 Testing in Urothelial Carcinoma: An Expert Commentary on Best Practices From Patient Identification to Result ReportingEva M Compérat, Arndt Hartmann, Yves Allory, et al.
Ebiomedicine|August 4, 2020
Vascular occlusion by neutrophil extracellular traps in COVID-19Moritz Leppkes, Jasmin Knopf, Elisabeth Naschberger, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 27, 2017
Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016Alessandro Lugli, Richard Kirsch, Yoichi Ajioka, et al.
Histopathology|June 27, 2022
WHO Classification of Tumours fifth edition: evolving issues in the classification, diagnosis, and prognostication of prostate cancerJames G Kench, Mahul B Amin, Daniel M Berney, et al.
Annals of the Rheumatic Diseases|August 17, 2024
CD19-CAR T-cell therapy induces deep tissue depletion of B cellsCarlo Tur, Markus Eckstein, Joachim Velden, et al.
Histopathology|March 9, 2025
Interobserver reproducibility of a hybrid three-tier grading system of papillary nonmuscle invasive urothelial carcinoma: an international Uropathology studyMichelle R Downes, Katherine Lajkosz, Ferran Algaba, et al.
European Urology|October 20, 2012
Prognostic value of perinodal lymphovascular invasion following radical cystectomy for lymph node-positive urothelial carcinomaHans-Martin Fritsche, Matthias May, Stefan Denzinger, et al.
Pageof 94

Showing results (811-820 of 933) with videos related to

Sort By:
Pageof 94
Cancers|April 30, 2021
Implementation of Double Immune Checkpoint Blockade Increases Response Rate to Induction Chemotherapy in Head and Neck CancerSabine Semrau, Antoniu-Oreste Gostian, Maximilian Traxdorf, et al.
European Journal of Cancer (Oxford, England : 1990)|December 12, 2018
Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumabMarkus Eckstein, Philipp Erben, Maximilian C Kriegmair, et al.
Geburtshilfe Und Frauenheilkunde|July 31, 2018
Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients - a Survey Among PhysiciansPaul Gass, Michael Untch, Volkmar Müller, et al.
European Urology Oncology|July 14, 2026
FGFR3 Testing in Urothelial Carcinoma: An Expert Commentary on Best Practices From Patient Identification to Result ReportingEva M Compérat, Arndt Hartmann, Yves Allory, et al.
Ebiomedicine|August 4, 2020
Vascular occlusion by neutrophil extracellular traps in COVID-19Moritz Leppkes, Jasmin Knopf, Elisabeth Naschberger, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 27, 2017
Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016Alessandro Lugli, Richard Kirsch, Yoichi Ajioka, et al.
Histopathology|June 27, 2022
WHO Classification of Tumours fifth edition: evolving issues in the classification, diagnosis, and prognostication of prostate cancerJames G Kench, Mahul B Amin, Daniel M Berney, et al.
Annals of the Rheumatic Diseases|August 17, 2024
CD19-CAR T-cell therapy induces deep tissue depletion of B cellsCarlo Tur, Markus Eckstein, Joachim Velden, et al.
Histopathology|March 9, 2025
Interobserver reproducibility of a hybrid three-tier grading system of papillary nonmuscle invasive urothelial carcinoma: an international Uropathology studyMichelle R Downes, Katherine Lajkosz, Ferran Algaba, et al.
European Urology|October 20, 2012
Prognostic value of perinodal lymphovascular invasion following radical cystectomy for lymph node-positive urothelial carcinomaHans-Martin Fritsche, Matthias May, Stefan Denzinger, et al.
Pageof 94